NCT03223324

Brief Summary

To study the equivalence of the Monica Novii™ Patch System in patients admitted for threatened pre-term labor and for pre-term labor \& delivery from 32 +0 weeks gestation by determining the equivalence of the Novii™ Patch System in monitoring Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contractions (UC) to Doppler FHR, tocodynamometer (TOCO) UC and photo plethysmograph MHR FDA approved predicates

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2017

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
Last Updated

September 23, 2019

Status Verified

September 1, 2019

Enrollment Period

11 months

First QC Date

May 4, 2017

Last Update Submit

September 20, 2019

Conditions

Keywords

Threatened Premature LaborAbdominal Fetal ECG

Outcome Measures

Primary Outcomes (1)

  • FHR Deming Regression

    Standard linear regression of y on x is not appropriate in this situation as the predicate device is not considered a gold standard, but as a device providing a measurement which may itself be subject to error, whereas the standard linear regression method assumes x to be measured without error. Deming regression is a method for calculating the regression line y=α+βx when both variables are subject to error, and the ratio of the error variances in x and y is known (and will be assumed to be equal to 1 in this analysis).

    30min

Secondary Outcomes (7)

  • FHR Percent Agreement

    30min

  • FHR Bland Altman

    30min

  • MHR Percent agreement

    30min

  • MHR bland altman

    30min

  • UC percent agreement

    30min

  • +2 more secondary outcomes

Study Arms (1)

Pre Term and Threatened Pre-Term Labor

abdominal fetal/maternal monitoring

Device: abdominal fetal/maternal monitor

Interventions

A single passive patch placed on the abdomen that incorporates 5 electrodes and a monitoring device

Also known as: Novii Wireless Patch System
Pre Term and Threatened Pre-Term Labor

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects admitted for threatened pre-term labor (total of 30 subjects) will be recruited for the study according to the following strata: - 15 patients with a gestation equal to 32 weeks +0 days gestation but \< 34 weeks +4 days - 5 patients with a Body Mass Index (BMI) less than 29 - 5 patients with a BMI equal to 29 but less than 35 - 5 patients with a BMI equal to or more than 35 - 15 patients with a gestation equal to 34 weeks +4 days gestation but \< 37 weeks +0 days - 5 patients with a BMI less than 29 - 5 patients with a BMI equal to 29 but less than 35 - 5 patients with a BMI equal to or more than 35. In addition, subjects admitted for pre-term labor \& delivery (total of 30 subjects) will be recruited. following the same stratification plan as above.

You may qualify if:

  • She will require pre-term labor (at least 32 weeks 0 days gestation) monitoring with a singleton longitudinal, breech, transverse lie pregnancy.

You may not qualify if:

  • The presence of any of the following factors or conditions would exclude the patient from consideration as a subject:
  • Known major fetal malformation or chromosome abnormality.
  • Multiple gestation
  • A condition for which cesarean will likely be carried out shortly.
  • Involvement in another clinical trial currently or previously in this pregnancy that, in the investigator's opinion, would affect the conduct of this study.
  • Medical or obstetric problem that would preclude the use of abdominal electrodes (e.g., skin eruptions, history of sensitivity to adhesives).
  • Parturient is under age 18.
  • Medical or obstetric problem that in investigator's opinion would make the patient incapable of taking part in the study.
  • Inability to understand the consent information due to medical illness or diminished intellectual capacity, or insurmountable language barrier.
  • Potential for coercion, e.g. Prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale dei Bambini Vittore Buzzi, Via Lodovico Castelvetro, 32

Milan, 20154, Italy

Location

MeSH Terms

Conditions

Obstetric Labor, Premature

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Enrico Ferrazzi, Professor

    l'Università degli Studi di Milano

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2017

First Posted

July 21, 2017

Study Start

July 2, 2016

Primary Completion

May 30, 2017

Study Completion

May 30, 2017

Last Updated

September 23, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations